| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.7M | -1.2% |
| Cost of Revenue | $27.0M | +11.0% |
| R&D Expense | $19.6M | +50.9% |
| SG&A Expense | $11.7M | -4.2% |
| Operating Income | -$5.5M | -240.4% |
| Pre-tax Income | -$5.6M | -235.0% |
| Income Tax | $996K | -18.5% |
| Net Income | -$6.6M | -325.2% |
| EPS (Basic) | -$0.08 | -300.0% |
| EPS (Diluted) | -$0.08 | -300.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.7M | -25.7% |
| Accounts Receivable | $8.8M | +203.9% |
| Inventory | $25.7M | +21.1% |
| Current Assets | $66.7M | +11.0% |
| Total Assets | $82.3M | +12.2% |
| Current Liabilities | $26.5M | +3.5% |
| Total Liabilities | $34.1M | +12.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | -238.3% |
| Capital Expenditures | $1.6M | +27.8% |
| Investing Cash Flow | -$2.4M | -156.1% |
| Financing Cash Flow | $9.3M | +155.5% |
| Free Cash Flow | -$13.6M | -284.4% |
| $48.2M |
| +11.6% |